Bills · S. 5736 · Text

Introduced in Senate

Confirmed from the official record

Our copy of the file on govinfo.gov, saved November 21, 2026. Fingerprint (SHA-256): 4b213a2ea21b31f5.

S. 5736: the bill

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[S. 5736 Introduced in Senate (IS)]

<DOC>






119th CONGRESS
  2d Session
                                S. 5736

     To amend the Agricultural Marketing Act of 1946 to modify the 
        definition of the term ``hemp'', and for other purposes.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                           November 17, 2026

  Mr. Sheehy (for himself and Ms. Klobuchar) introduced the following 
  bill; which was read twice and referred to the Committee on Health, 
                     Education, Labor, and Pensions

_______________________________________________________________________

                                 A BILL


 
     To amend the Agricultural Marketing Act of 1946 to modify the 
        definition of the term ``hemp'', and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Hemp Guardrails Act''.

SEC. 2. HEMP.

    (a) Definition of Hemp.--
            (1) In general.--Section 297A(1) of the Agricultural 
        Marketing Act of 1946 (7 U.S.C. 1639o(1)) (as amended by 
        section 781 of the Agriculture, Rural Development, Food and 
        Drug Administration, and Related Agency Appropriations Act, 
        2026 (7 U.S.C. 1639o note; Public Law 119-37)), is amended--
                    (A) in subparagraph (A), by striking ``0.3'' and 
                inserting ``1.0'';
                    (B) in subparagraph (C)--
                            (i) in clause (i)--
                                    (I) by striking ``0.3'' and 
                                inserting ``1.0''; and
                                    (II) by striking ``or'' after the 
                                semicolon;
                            (ii) in clause (ii)--
                                    (I) by striking subclauses (II) and 
                                (III); and
                                    (II) by striking ``containing--'' 
                                and all that follows through 
                                ``cannabinoids'' in subclause (I) and 
                                inserting ``containing cannabinoids''; 
                                and
                            (iii) in clause (iv)--
                                    (I) in subclause (I), by adding 
                                ``or'' after the semicolon at the end; 
                                and
                                    (II) by striking subclauses (II) 
                                and (III) and inserting the following:
                                    ``(II) more than trace amounts of 
                                restricted cannabinoids.''; and
                    (C) by adding at the end the following:
                    ``(D) Restricted cannabinoids.--For purposes of 
                subparagraph (C)(iv), the term `restricted 
                cannabinoids'--
                            ``(i) means cannabinoids, other than delta-
                        9 tetrahydrocannabinol, that produce 
                        intoxication or impairment in humans through 
                        agonism of the cannabinoid CB1 receptor, 
                        including delta-8 tetrahydrocannabinol, delta-
                        10 tetrahydrocannabinol, hexahydrocannabinol 
                        (HHC), and tetrahydrocannabinol acetate (THC-O-
                        acetate), together with their isomers, analogs, 
                        esters, ethers, and salts; and
                            ``(ii) does not include cannabidiol (CBD), 
                        cannabinol (CBN), cannabigerol (CBG), 
                        cannabichromene (CBC), cannabidivarin (CBDV), 
                        tetrahydrocannabivarin (THCV), or delta-9 
                        tetrahydrocannabinol.
                    ``(E) Unfinished hemp-cannabinoid ingredients.--
                Notwithstanding any other provision of this paragraph, 
                an unfinished hemp-cannabinoid ingredient (as defined 
                in section 201 of the Federal Food, Drug, and Cosmetic 
                Act (21 U.S.C. 321)) shall be considered hemp under 
                this subtitle.''.
            (2) Technical and conforming amendments.--
                    (A) State and tribal plans.--Section 297B of the 
                Agricultural Marketing Act of 1946 (7 U.S.C. 1639p) is 
                amended--
                            (i) in subsection (a)(2)(A)(ii), by 
                        striking ``delta-9 tetrahydrocannabinol 
                        concentration'' and inserting ``total 
                        tetrahydrocannabinols concentration (including 
                        tetrahydrocannabinolic acid)''; and
                            (ii) in subsection (e)(2)(A)(iii), by 
                        striking ``delta-9 tetrahydrocannabinol 
                        concentration of more than 0.3 percent'' and 
                        inserting ``total tetrahydrocannabinols 
                        concentration (including tetrahydrocannabinolic 
                        acid) of more than 1.0 percent''.
                    (B) Department of agriculture plan.--Section 
                297C(a)(2)(B) of the Agricultural Marketing Act of 1946 
                (7 U.S.C. 1639q(a)(2)(B)) is amended by striking 
                ``delta-9 tetrahydrocannabinol concentration'' and 
                inserting ``total tetrahydrocannabinols concentration 
                (including tetrahydrocannabinolic acid)''.
    (b) Amendments to the Federal Food, Drug, and Cosmetic Act.--
            (1) Definitions.--Section 201 of the Federal Food, Drug, 
        and Cosmetic Act (21 U.S.C. 321) is amended--
                    (A) in paragraph (s), in the matter preceding 
                subparagraph (1), by striking ``food (including any 
                substance'' and inserting ``food (including industrial 
                hemp intended for human or animal use and hemp seed, 
                hemp seed oil, or hempseed protein not containing 
                cannabinoids, any substance'';
                    (B) in paragraph (rr), by adding at the end the 
                following:
    ``(6) The term `tobacco product' does not include a hemp-derived 
cannabinoid product.''; and
                    (C) by adding at the end the following:
    ``(tt) The term `hemp-derived cannabinoid product'--
            ``(1) except as otherwise provided in subparagraph (2), has 
        the meaning given the term in section 297A of the Agricultural 
        Marketing Act of 1946;
            ``(2) may include an intermediate hemp-derived cannabinoid 
        product (as defined in section 297A of the Agricultural 
        Marketing Act of 1946) only in such cases as the Secretary 
        determines appropriate;
            ``(3) includes a hemp-derived cannabinoid dietary 
        supplement;
            ``(4) may include ingestibles, beverages, oral tinctures 
        and sublinguals, capsules and tablets, inhalables (other than 
        raw floral hemp material, smokable hemp flower, or pre-roll 
        material that is intended for inhalation), and topicals and 
        transdermals; and
            ``(5) does not include--
                    ``(A) a drug that is subject to the requirements of 
                chapter V or section 351 of the Public Health Service 
                Act;
                    ``(B) a device that is subject to the requirements 
                of chapter V; or
                    ``(C) an unfinished hemp-cannabinoid ingredient.
    ``(uu) The term `hemp-derived cannabinoid dietary supplement'--
            ``(1) means a dietary supplement that--
                    ``(A) contains one or more ingredients that are 
                derived from hemp;
                    ``(B) contains one or more cannabinoids; and
                    ``(C) is for ingestion in tablet, capsule, softgel, 
                gelcap, powder, gummy, chew, lozenge, tincture, oil, 
                spray, strip, or liquid form;
            ``(2) is not marketed for its impairing effects; and
            ``(3) does not include--
                    ``(A) any product for inhalation, application to 
                the skin, or transdermal absorption;
                    ``(B) any product containing raw floral hemp 
                material, an unfinished hemp-cannabinoid ingredient, or 
                work-in-process materials;
                    ``(C) any product containing industrial hemp;
                    ``(D) any product containing hemp seed, hemp seed 
                oil, or hempseed protein not containing cannabinoids; 
                or
                    ``(E) any product containing any cannabinoid not 
                found in, or capable of being produced in, the hemp 
                plant.
    ``(vv) The term `hemp' has the meaning given such term in section 
297A of the Agricultural Marketing Act of 1946.
    ``(ww) The term `unfinished hemp-cannabinoid ingredient' means an 
oil, extract, concentrate, distillate, or other intermediate substance 
that--
            ``(1) meets the criteria specified in subparagraphs (A) 
        through (D) of section 297A(1) of the Agricultural Marketing 
        Act of 1946 to be considered hemp, except that such substance 
        may contain a concentration of total tetrayhdrocannabinol that 
        exceeds 1 percent during processing, on the conditions that 
        such substance--
                    ``(A) remains exclusively with actors or entities 
                lawfully permitted to manufacture hemp-derived 
                cannabinoid products under this Act; and
                    ``(B) is not offered for retail sale;
            ``(2) is not for consumer use;
            ``(3) is not marketed, sold, distributed, or shipped to any 
        actors or entities other than actors or entities lawfully 
        permitted to manufacture hemp-derived cannabinoid products 
        under this Act;
            ``(4) is not a finished hemp product; and
            ``(5) is produced solely for incorporation into a finished 
        cannabinoid product through further processing.''.
            (2) Prohibited acts.--Section 301 of the Federal Food, 
        Drug, and Cosmetic Act (21 U.S.C. 331) is amended--
                    (A) by inserting ``hemp-derived cannabinoid 
                product,'' after ``tobacco product,'' each place it 
                appears in paragraphs (a), (b), (c), (g), (h), and (k);
                    (B) in paragraph (p)--
                            (i) by striking ``510 or 905'' and 
                        inserting ``510, 905, or 1103''; and
                            (ii) by striking ``or 905(j)'' and 
                        inserting ``905(j), or 1103''; and
                    (C) by adding at the end the following:
    ``(jjj)(1) The introduction or delivery for introduction into 
interstate commerce of any food to which has been added a hemp-derived 
cannabinoid product, unless the finished product complies with the 
requirements for food under chapter IV and for hemp-derived cannabinoid 
products under chapter XI.
    ``(2) The introduction or delivery for introduction into interstate 
commerce of a hemp-derived cannabinoid product that is not derived 
exclusively from hemp cultivated in the United States, processed within 
the United States, and finished, packaged, and labeled within the 
United States.
    ``(3) The sale of a hemp-derived cannabinoid product to any person 
younger than 21 years of age.
    ``(4) The possession or consumption of a hemp-derived cannabinoid 
product by any person younger than 21 years of age.
    ``(5) The sale of a hemp-derived cannabinoid product that does not 
comply with the child-resistant packaging requirements established by 
regulations promulgated under section 1103.
    ``(6) The introduction or delivery for introduction into interstate 
commerce of a hemp-derived cannabinoid product intended for human 
consumption that contains, or purports to contain, raw floral hemp 
material, smokable flower, or pre-roll material that is intended for 
inhalation.''.
            (3) Regulation of hemp-derived cannabinoid products.--The 
        Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.) is 
        amended by adding at the end the following:

            ``CHAPTER XI--HEMP-DERIVED CANNABINOID PRODUCTS

``SEC. 1101. MISBRANDING.

    ``A hemp-derived cannabinoid product shall be deemed to be 
misbranded if--
            ``(1) its advertising or promotion is false or misleading 
        in any particular;
            ``(2) its labeling does not bear adequate directions for 
        use, or adequate warnings against use by children, that are 
        necessary for the protection of users, or conform to such other 
        requirements in all respects as may be prescribed by the 
        Secretary;
            ``(3) it is in package form for use by humans, and it 
        contains product packaging features imitating images popularly 
        used to advertise to children or otherwise market to anyone 
        under 21 years of age, as determined by the Secretary; or
            ``(4) it fails to comply with any applicable requirement 
        established under section 1103(1).

``SEC. 1102. ADULTERATION.

    ``A hemp-derived cannabinoid product shall be deemed to be 
adulterated if it fails to comply with any applicable requirement 
established under paragraph (2) or (3) of section 1103.

``SEC. 1103. HEMP-DERIVED CANNABINOID PRODUCT STANDARDS.

    ``Not later than 180 days after the date of enactment of this 
chapter, the Secretary shall establish, by regulation--
            ``(1) packaging and labeling requirements for hemp-derived 
        cannabinoid products, which shall include--
                    ``(A) child-resistant packaging requirements, which 
                may vary based on the form, characteristics, and 
                intended use of the hemp-derived cannabinoid product; 
                and
                    ``(B) requirements that final hemp-derived 
                cannabinoid products bear a label containing a quick 
                response (QR) code, any other scannable mechanism, or 
                internet address that leads to a web page with testing 
                results for the cannabinoid hemp product in the form of 
                a certificate of analysis;
            ``(2) uniform manufacturing and testing requirements for 
        hemp-derived cannabinoid products to ensure safety of such 
        products, which shall include--
                    ``(A) manufacturing and testing requirements for 
                key components, potential contaminants, and cannabinoid 
                content;
                    ``(B) requirements for third-party laboratory 
                testing of finished products; and
                    ``(C) good manufacturing practice requirements for 
                facilities producing hemp-derived cannabinoid products;
            ``(3) requirements for the identification, evaluation, and 
        control of added substances in hemp-derived cannabinoid 
        products;
            ``(4) requirements for the recall and removal from commerce 
        of hemp-derived cannabinoid products that are adulterated, 
        misbranded, or otherwise fail to comply with applicable safety 
        requirements that may be prescribed by the Secretary; and
            ``(5) registration and recordkeeping requirements for 
        facilities engaged in manufacturing, processing, packing, or 
        holding of hemp-derived cannabinoid products intended for 
        distribution in the United States.

``SEC. 1104. DIETARY SUPPLEMENTS CONTAINING CANNABINOIDS.

    ``(a) In General.--A dietary supplement that is a hemp-derived 
cannabinoid product shall comply with all applicable requirements for 
dietary supplements and food under chapter IV and all applicable 
requirements for hemp-derived cannabinoid products under this chapter.
    ``(b) Effect.--A dietary supplement that is also a hemp-derived 
cannabinoid product shall not be--
            ``(1) deemed adulterated under section 402(f) solely on 
        account of constituents made or derived from cannabinoids; or
            ``(2) excluded from the definition of dietary supplement 
        under section 201(ff)(3) solely on account of constituents made 
        or derived from cannabis.''.
            (4) Seizure.--Section 304(a)(2) of the Federal Food, Drug, 
        and Cosmetic Act (21 U.S.C. 334) is amended by striking the 
        period at the end and adding the following: ``Any adulterated 
        or misbranded hemp-derived cannabinoid product.''.
            (5) Food additives.--Section 409(a) of the Federal Food, 
        Drug, and Cosmetic Act (21 U.S.C. 348(a)) is amended by adding 
        at the end of the matter following paragraph (3) the following: 
        ``A food bearing or containing a hemp-derived cannabinoid 
        product that meets the requirements of chapter XI shall not, by 
        reason of bearing or containing such a hemp-derived cannabinoid 
        product, be considered adulterated under subparagraph (1) or 
        (2)(C)(i) of section 402(a).''.
            (6) Inspection.--Section 704(a)(1) of the Federal Food, 
        Drug, and Cosmetic Act (21 U.S.C. 374(a)(1)) is amended, in the 
        first sentence, in subparagraph (A), by inserting ``hemp-
        derived cannabinoid products,'' after ``tobacco products,'' 
        each place it appears.
            (7) Publicity.--Section 705(b) of the Federal Food, Drug, 
        and Cosmetic Act (21 U.S.C. 375(b)) is amended by inserting 
        ``hemp-derived cannabinoid products,'' after ``tobacco 
        products,''.
            (8) Presumption.--Section 709 of the Federal Food, Drug, 
        and Cosmetic Act (21 U.S.C. 379a) is amended by inserting 
        ``hemp-derived cannabinoid product,'' after ``tobacco 
        product,''.
            (9) Rule of construction.--Nothing in this section shall be 
        construed to alter, limit, supersede, or terminate the 
        authority of the Secretary--
                    (A) to administer the Substance Access Beneficiary 
                Engagement Incentive or any successor program under the 
                Centers for Medicare & Medicaid Services involving 
                hemp-derived cannabinoid dietary supplements (as 
                defined in section 201(uu) of the Federal Food, Drug, 
                and Cosmetic Act (21 U.S.C. 321(uu))); or
                    (B) permit coverage of a hemp-derived cannabinoid 
                dietary supplement (as so defined) as a supplemental 
                benefit under section 1852(a)(3)(D) of the Social 
                Security Act (42 U.S.C. 1395w-22(a)(3)(D)).
    (c) Protection of State Regulatory Authority and Interstate 
Commerce.--
            (1) Preservation of state rights.--Except as provided in 
        paragraph (2), nothing in this section or the amendments made 
        by this section shall be construed to preempt or limit the 
        authority of a State, territory, or Indian Tribe to enact or 
        enforce laws and regulations governing the production, 
        manufacture, distribution, importation, or sale of hemp or 
        hemp-derived cannabinoid products within the borders, or 
        exportation out of the borders, of such State, territory, or 
        Indian Tribe that are more stringent than, or at least as 
        protective as, the standards in this section and the amendments 
        made by this section.
            (2) Non-interference with interstate commerce.--Pursuant to 
        clause 3 of section 8 of Article I, United States Constitution, 
        no State, territory, or Indian Tribe may enact or enforce any 
        law that prevents the passage and delivery of a hemp-derived 
        cannabinoid product through the borders of such State, 
        territory, or Indian Tribe if such product complies with this 
        section and the amendments made by this section.
            (3) Definitions.--In this subsection, the terms ``hemp'' 
        and ``hemp-derived cannabinoid product'' have the meanings 
        given the terms in section 297A of the Agricultural Marketing 
        Act of 1946 (7 U.S.C. 1639o), as amended by subsection (a).
    (d) Effective Date.--This section and the amendments made by this 
section shall take effect on December 11, 2026.
                                 <all>
Suggest a tool

Suggest a tool

A person reads each idea before it appears. Links are not accepted. Do not include personal information.

See all ideas and vote